Therefore, whereas the pathology of normal aging and that of AD differ more quantitatively than qualitatively, heavy tau “burden” is generally incompatible with preserved cerebral function, while heavy amyloid burden is often tolerated. The gene discussed is MAPT; the disease is Alzheimer disease.